Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

NCT05028660 is registered in ClinicalTrials.gov with Elypta as lead sponsor.

NCT NCT05028660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study
Lead sponsor
Elypta
Phase
Observational
Overall status
Completed
Start date
July 21, 2021
Completion date
April 30, 2025
Enrollment
43 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

muscle-invasive bladder carcinoma